Top-News
Montag,
14.07.2014 13:50
von
PR Newswire
| Aufrufe: 215
Elsevier Announces Launch of New Journal: Current Opinion in Insect Science
pixabay.com
PR Newswire
NEW YORK, July 14, 2014
NEW YORK, July 14, 2014 /PRNewswire/ --
First published articles now available for free online on ScienceDirect
How does oxygen control insect body size? What influence does genetics have on insects' social structure? Articles published in the first issue of Current Opinion in Insect Science - launched today - aims to answer these and more questions.
Current Opinion in Insect Science is the latest title in Elsevier's Current Opinion journal series. It is a review journal that aims to provide specialists with a unique platform to keep up-to-date with the expanding volume of information published in the field of insect science. First articles published are now available for free on ScienceDirect.
Professor David Denlinger (Ohio State University, Columbus, OH, USA) and Dr. Jeff Harvey (Netherlands Institute of Ecology) lead the editorial board.
"Initially I was reluctant to launch a new journal as there are so many out there already," said Denlinger. "I soon realized the unique niche defined by Elsevier's Current Opinion series however. This addition to the series offers an exciting way to keep the growing community of insect scientists up to date on diverse hot topics affecting our field."
"Following the success of the Molecular Insect Science conference held in Amsterdam in 2011, we started to develop the idea of a new Current Opinion title that could encompass the expanding amount of research in the insect science discipline," said Dale Seaton, Executive Publisher Biological Sciences at Elsevier. "With David and Jeff's leadership we have assembled a series of topical reviews from the world's leading scientists that will provide essential reading updates for the insect research community."
ARIVA.DE Börsen-Geflüster
Kurse
 |
 |
 |
The first issue of Current Opinion in Insect Science is available for free on ScienceDirect
For more information about Current Opinion in Insect Science, or to submit an article, go to: http://www.elsevier.com/locate/cois
About the editors
David Denlinger is a Distinguished University Professor at the Ohio State University. He has published more than 300 peer-reviewed articles and has co-edited several books. He was the co-editor of the Journal of Insect Physiology. Denlinger's recent research has focused on molecular and physiological mechanisms regulating insect diapause and cold hardiness.
Jeff Harvey is a senior scientist at the Netherlands Institute of Ecology and former Associate Editor of Nature. Harvey's research focuses on life history strategies in parasitoids and hyperparasitoids, plantherbivore-parasitoid interactions and community ecology; science and advocacy.
About Elsevier
Elsevier is a world-leading provider of information solutions that enhance the performance of science, health, and technology professionals, empowering them to make better decisions, deliver better care, and sometimes make groundbreaking discoveries that advance the boundaries of knowledge and human progress. Elsevier provides web-based, digital solutions - among them ScienceDirect, Scopus, Elsevier Research Intelligence, and ClinicalKey - and publishes nearly 2,200 journals, including The Lancet and Cell, and over 25,000 book titles, including a number of iconic reference works.
The company is part of Reed Elsevier Group PLC, a world leading provider of professional information solutions in the Science, Medical, Legal and Risk and Business sectors, which is jointly owned by Reed Elsevier PLC and Reed Elsevier NV. The ticker symbols are REN (Euronext Amsterdam), REL (London Stock Exchange), RUK and ENL (New York Stock Exchange).
Media contact
Jason Awerdick
Elsevier
+1-212-633-3103
j.awerdick@elsevier.com
Werbung
Mehr Nachrichten zur RELX Group Aktie kostenlos abonnieren
E-Mail-Adresse
Bitte überprüfe deine die E-Mail-Adresse.
Benachrichtigungen von ARIVA.DE
(Mit der Bestellung akzeptierst du die Datenschutzhinweise)
(Mit der Bestellung akzeptierst du die Datenschutzhinweise)
-1
Vielen Dank, dass du dich für unseren Newsletter angemeldet hast. Du erhältst in Kürze eine E-Mail mit einem Aktivierungslink.
Hinweis: ARIVA.DE veröffentlicht in dieser Rubrik Analysen, Kolumnen und Nachrichten aus verschiedenen Quellen. Die ARIVA.DE AG ist nicht verantwortlich für Inhalte, die erkennbar von Dritten in den „News“-Bereich dieser Webseite eingestellt worden sind, und macht sich diese nicht zu Eigen. Diese Inhalte sind insbesondere durch eine entsprechende „von“-Kennzeichnung unterhalb der Artikelüberschrift und/oder durch den Link „Um den vollständigen Artikel zu lesen, klicken Sie bitte hier.“ erkennbar; verantwortlich für diese Inhalte ist allein der genannte Dritte.
